Our results fit with a study by Beatty et al., reporting that in patients with ischaemic heart disease, those with a higher concentration of adiponectin suffered a significantly higher risk of developing heart failure and death, compared to those with a lower concentration [85]. This evidence concerns the gene ADIPOQ and heart disorder.